Addus HomeCare Corporation (ADUS) vs Alamar Biosciences, Inc. (ALMR)
A side-by-side comparison of Addus HomeCare Corporation and Alamar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADUS
Addus HomeCare Corporation
$113.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ALMR
Alamar Biosciences, Inc.
$32.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ADUS vs ALMR
growth of $100 · dividends reinvested · last 1yADUS +21.1% (+21.1%/yr)ALMR +73.3% (+73.3%/yr)ALMR compounded faster over this window
ADUS ALMR
ADUS vs ALMR: by the numbers
- •ALMR is the larger company ($2.24B vs $2.11B market cap).
- •ADUS is profitable (7.13% net margin) while ALMR runs a net loss (-40.18%).
Metrics side by side
Valuation
| Metric | ADUS | ALMR |
|---|---|---|
| P/E ratio | 19.85 | N/A |
| Forward P/E | 16.06 | N/A |
| PEG ratio | 0.98 | N/A |
| P/S ratio | 1.43 | N/A |
| P/B ratio | 1.84 | 7.15 |
| EV / EBITDA | 12.86 | N/A |
| FCF yield | 7.25% | N/A |
Profitability
| Metric | ADUS | ALMR |
|---|---|---|
| Gross margin | 32.36% | 56.20% |
| Operating margin | 10.04% | -42.22% |
| Net margin | 7.13% | -40.18% |
| ROE | 9.17% | N/A |
| ROIC | 8.61% | -26.95% |
Growth (annualized)
| Metric | ADUS | ALMR |
|---|---|---|
| Revenue CAGR (5Y) | 12.67% | N/A |
| EPS CAGR (5Y) | 19.61% | N/A |
| FCF CAGR (5Y) | 24.41% | N/A |
| Total return CAGR (5Y) | 8.33% | N/A |
Frequently asked
- Is ADUS or ALMR more profitable?
- ADUS runs the higher net margin — ADUS at 7.13% versus ALMR at -40.18%.
Go deeper
Dig into the metrics
Addus HomeCare P/E ratioAddus HomeCare ROEAlamar Biosciences ROEAddus HomeCare operating marginAlamar Biosciences operating marginAddus HomeCare revenue growthAlamar Biosciences revenue growthAddus HomeCare free cash flowAlamar Biosciences free cash flow
Addus HomeCare & Alamar Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.